N-(4-Methylbenzyl)-2-[(3-phenyl-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamide

ID: ALA2298880

PubChem CID: 47082787

Max Phase: Preclinical

Molecular Formula: C26H21N5O2S

Molecular Weight: 467.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(CNC(=O)CSc2nc3ccccc3c3nc(=O)c(-c4ccccc4)nn23)cc1

Standard InChI:  InChI=1S/C26H21N5O2S/c1-17-11-13-18(14-12-17)15-27-22(32)16-34-26-28-21-10-6-5-9-20(21)24-29-25(33)23(30-31(24)26)19-7-3-2-4-8-19/h2-14H,15-16H2,1H3,(H,27,32)

Standard InChI Key:  BHRNPQYGAFLEAN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   29.3527  -20.8374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3516  -21.6648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0663  -22.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0645  -20.4247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7799  -20.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7788  -21.6623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2115  -20.8358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4940  -20.4182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9270  -20.4251    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   33.6405  -20.8393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3559  -20.4285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0694  -20.8427    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3579  -19.6035    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.7848  -20.4320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2104  -21.6643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.4919  -22.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4884  -22.8980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2016  -23.3166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9201  -22.9058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9253  -22.0766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1970  -24.1415    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6324  -23.3221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4984  -20.8462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4910  -21.6719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2037  -22.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9200  -21.6752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9194  -20.8459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2062  -20.4355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6341  -22.0884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6261  -24.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3375  -24.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0552  -24.1543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0570  -23.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3449  -22.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6 16  1  0
 15  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 15 16  1  0
 15 20  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 18 21  2  0
 19 22  1  0
 14 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
 22 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 22  1  0
M  END

Associated Targets(Human)

BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 393 (41971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Malme-3M (44254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-539 (44845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-75 (44215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Photobacterium leiognathi (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.55Molecular Weight (Monoisotopic): 467.1416AlogP: 4.02#Rotatable Bonds: 6
Polar Surface Area: 89.25Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.85CX LogP: 4.69CX LogD: 4.69
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.83

References

1. Kovalenko SI, Nosulenko IS, Voskoboynik AY, Berest GG, Antipenko LN, Antipenko AN, Katsev AM.  (2013)  Novel N-aryl(alkaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides: synthesis, cytotoxicity, anticancer activity, COMPARE analysis and docking,  22  (6): [10.1007/s00044-012-0257-x]

Source